These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2466855)
21. [Diabetic maculopathy and proliferative retinopathy: their relation and the results of photocoagulation]. Nikolić Lj; Radović N Srp Arh Celok Lek; 1985 Aug; 113(8):655-63. PubMed ID: 2418513 [No Abstract] [Full Text] [Related]
22. Time span of regression or disappearance of optic disk neovascularisation in proliferative diabetic retinopathy after panretinal argon laser photocoagulation and results over a two-year follow-up. Theodossiadis GP; Ismiridis KJ Fortschr Ophthalmol; 1987; 84(5):465-7. PubMed ID: 2448214 [No Abstract] [Full Text] [Related]
23. A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Blankenship GW Ophthalmology; 1988 Feb; 95(2):170-7. PubMed ID: 2459641 [TBL] [Abstract][Full Text] [Related]
24. Macular edema after scatter laser photocoagulation for proliferative diabetic retinopathy. Meyers SM Am J Ophthalmol; 1980 Aug; 90(2):210-6. PubMed ID: 6158867 [TBL] [Abstract][Full Text] [Related]
25. [Results of laser photocoagulation in diabetic retinopathy with maculopathy]. Palacz O; Sylwestrzak Z; Oszczyk U Klin Oczna; 1991; 93(10-11):306-7. PubMed ID: 1726495 [TBL] [Abstract][Full Text] [Related]
27. Argon green vs krypton red laser photocoagulation of extrafoveal choroidal neovascular lesions. One-year results in age-related macular degeneration. The Canadian Ophthalmology Study Group. Arch Ophthalmol; 1993 Feb; 111(2):181-5. PubMed ID: 7679269 [TBL] [Abstract][Full Text] [Related]
28. Dye laser treatment in proliferative diabetic retinopathy and maculopathy. Atmaca LS; Idil A; Gündüz K Acta Ophthalmol Scand; 1995 Aug; 73(4):303-7. PubMed ID: 8646573 [TBL] [Abstract][Full Text] [Related]
29. A comparative trial of xenon arc and argon laser photocoagulation in the treatment of proliferative diabetic retinopathy. Plumb AP; Swan AV; Chignell AH; Shilling JS Br J Ophthalmol; 1982 Apr; 66(4):213-8. PubMed ID: 6175340 [TBL] [Abstract][Full Text] [Related]
30. Experiments on the absorption of argon and krypton laser by blood. Folk JC; Shortt SG; Kleiber PD Ophthalmology; 1985 Jan; 92(1):100-8. PubMed ID: 2579360 [TBL] [Abstract][Full Text] [Related]
31. Retinal photocoagulation (xenon arc and lasers). François J; Cambie E Ann Ophthalmol; 1971 Nov; 3(11):1201-8. PubMed ID: 5170789 [No Abstract] [Full Text] [Related]
32. Fifteen-year argon laser and xenon photocoagulation results of Bascom Palmer Eye Institute's patients participating in the diabetic retinopathy study. Blankenship GW Ophthalmology; 1991 Feb; 98(2):125-8. PubMed ID: 2008268 [TBL] [Abstract][Full Text] [Related]
33. [Recurrence of vasoproliferative activity after photocoagulation. A fluorescence-angiographic study]. Prskavec FH; Klemen UM; Frey C; Gnad HD Wien Klin Wochenschr; 1985 Aug; 97(15):627-30. PubMed ID: 4049888 [TBL] [Abstract][Full Text] [Related]
34. Extensive argon laser photocoagulation in the treatment of proliferative diabetic retinopathy. Aylward GW; Pearson RV; Jagger JD; Hamilton AM Br J Ophthalmol; 1989 Mar; 73(3):197-201. PubMed ID: 2468355 [TBL] [Abstract][Full Text] [Related]